140 related articles for article (PubMed ID: 35223330)
1. Clinical Correlation and Role of Cyclin D1 Expression in Glioblastoma Patients: A Study From North India.
Jaiswal M; Tripathi A; Singh D; Kumar A; Singh M; Batra N; Verma A
Cureus; 2022 Feb; 14(2):e22346. PubMed ID: 35223330
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclin D1 in glial tumors-A retrospective and observational study.
Mehta R; Yadav R; Vatsgotra R
Indian J Pathol Microbiol; 2023; 66(2):264-268. PubMed ID: 37077066
[TBL] [Abstract][Full Text] [Related]
3. Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.
Camacho-Urkaray E; Santos-Juanes J; Gutiérrez-Corres FB; García B; Quirós LM; Guerra-Merino I; Aguirre JJ; Fernández-Vega I
Cell Oncol (Dordr); 2018 Apr; 41(2):213-221. PubMed ID: 29218546
[TBL] [Abstract][Full Text] [Related]
4. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
[TBL] [Abstract][Full Text] [Related]
5. An Immunohistochemical Study of Cyclin D1 Expression in Astrocytic Tumors and its Correlation with Tumor Grade.
Mahzouni P; Taheri F
Iran J Pathol; 2019; 14(3):252-257. PubMed ID: 31583003
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
[TBL] [Abstract][Full Text] [Related]
7. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
8. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.
Liu C; Tu Y; Sun X; Jiang J; Jin X; Bo X; Li Z; Bian A; Wang X; Liu D; Wang Z; Ding L
Clin Exp Med; 2011 Jun; 11(2):105-12. PubMed ID: 20809334
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
10. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
Büschges R; Weber RG; Actor B; Lichter P; Collins VP; Reifenberger G
Brain Pathol; 1999 Jul; 9(3):435-42; discussion 432-3. PubMed ID: 10416984
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells.
Wang J; Wang Q; Cui Y; Liu ZY; Zhao W; Wang CL; Dong Y; Hou L; Hu G; Luo C; Chen J; Lu Y
J Neurooncol; 2012 Feb; 106(3):473-84. PubMed ID: 21912938
[TBL] [Abstract][Full Text] [Related]
12. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic cyclin D1 regulates glioblastoma dissemination.
Cemeli T; Guasch-Vallés M; Nàger M; Felip I; Cambray S; Santacana M; Gatius S; Pedraza N; Dolcet X; Ferrezuelo F; Schuhmacher AJ; Herreros J; Garí E
J Pathol; 2019 Aug; 248(4):501-513. PubMed ID: 30957234
[TBL] [Abstract][Full Text] [Related]
14. Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies.
Dong M; Wei H; Hou JM; Gao S; Yang DZ; Lin ZH; Jia Y; Ren XP; Gao MH
Int J Clin Exp Pathol; 2014; 7(7):3975-83. PubMed ID: 25120774
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population.
Mathew R; Arora S; Khanna R; Shukla NK; Mathur M; Ralhan R
J Cancer Res Clin Oncol; 2001 Apr; 127(4):251-7. PubMed ID: 11315260
[TBL] [Abstract][Full Text] [Related]
19. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas.
Liu W; Lv G; Li Y; Li L; Wang B
J Exp Clin Cancer Res; 2011 Aug; 30(1):76. PubMed ID: 21843312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
